Oaktree Acquisition Corp. III Life Sciences OACC
Nasdaq · XNAS · stock · Blank Checks · IPO 2024-12-16
Oaktree Acquisition Corp. III Life Sciences statistics & valuation
Market cap$262.3M
P / E36.0×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 |
|---|---|
| Return on assets | 3.6% |
| Return on equity | -107.7% |
| Current ratio | 1.19 |
Source: SEC EDGAR filings · CIK 0002029769 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.